RENININHIBITOREN
European patent · EP2097377 · Deleted
Register entry
- Publication number
- EP2097377
- Application number
- EP07845514
- Kind
- European patent with effect for Switzerland and Liechtenstein
- Status
- Deleted
- Specification
- Granted
- Filed
- Nov 14, 2007
- Published
- Sep 9, 2009
- Granted
- Jul 7, 2010
- Deleted
- Nov 30, 2013
- Reason
- Annual fee unpaid
- IPC classes
- C07D 211/60 (2006.01)A61K 31/451 (2006.01)A61K 31/4545 (2006.01)A61P 9/10 (2006.01)A61P 9/12 (2006.01)C07D 401/04 (2006.01)
- Priority
- US 859914 P 17.11.2006
- PCT application
- PCT/CA2007/002044 14.11.2007
- PCT publication
- WO2008/058387 22.05.2008
- Filing language
- English
- Source
- Swissreg
History
What the Federal Institute of Intellectual Property published about this title, newest first.
- Jun 18, 2014
Deleted, fee unpaid
Published in Swissreg on 18.06.2014
- Jul 23, 2013
Address changed
- Owner
- Merck Frosst Canada Ltd., 16711 Trans-Canada Highway, Kirkland, Québec H9H 3L1, Canada → Merck Canada Inc., 16711 Trans Canada Highway, Kirkland, Quebec H9H 3L1, Canada
Published in Swissreg on 23.07.2013
- Jul 27, 2010
Agent entered
- Representative
- Servopatent GmbH, Resirain 1, 8125 Zollikerberg
Published in Swissreg on 27.07.2010
- Jul 7, 2010
Granted
Published in Swissreg on 07.07.2010
Parties
Inventor
DUBE, Daniel
Kirkland, Québec H9H 3L1, CA
GALLANT, Michel
Kirkland, Québec H9H 3L1, CA
GRIMM, Erich L.
Kirkland, Québec H9H 3L1, CA
JUTEAU, Helene
Kirkland, Québec H9H 3L1, CA
LALIBERTE, Sebastien
Kirkland, Québec H9H 3L1, CA
WU, Tom Yao-Hsiang
Kirkland, Québec H9H 3L1, CA
The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.